Life-span extension therapy: Resistin inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 10/June/2015, 8.48 pm

MiRNA-based therapy for leukaemia: MiRNA-149 suppresess B-cell lineage acute lymphoid leukaemia via down regulation of its target gene, 10/June/2015, 8.44 pm
June 10, 2015
MiRNA-based therapy for Age-associated dementia and Alzheimer’s disease (AD): MiRNA-214 increases the expression of AGE receptor 1 (AGER1), the longevity-promoting gene Sirtuin-1 and decreases advanced glycation end products (AGEs) via down regulation of its target gene, 10/June/2015, 9.30 pm
June 10, 2015
Show all

A recent study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 )by Prof Dominic J. Withers, Dr. Selman C and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports that:  Life-span extension therapy: Resistin inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene. 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Life-span extension therapy: Resistin inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 10/June/2015, 8.48 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that Resistin, by increasing the expression of its target gene, it may decrease the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase). Thereby, it may promote resistance to bone, immune, and motor dysfunction.   Thus, pharmacological formulations encompassing Resistin  activators may be used to extend the life span of an individual.

Undisclosed information: How Resistin decreases the expression of p70S6 Kinase

Comments are closed.